title: Lupus erythematosus-like skin eruption after vemurafenib therapy.
authors.affiliation: Department of Dermatology and Allergy, Ludwig-Maximilian-University, Munich, Germany. Electronic address: markus.reinholz@med.uni-muenchen.de.
authors.forename: Markus
authors.initials: M
authors.lastname: Reinholz
authors.affiliation: Department of Dermatology and Allergy, Ludwig-Maximilian-University, Munich, Germany.
authors.forename: Carola
authors.initials: C
authors.lastname: Berking
authors.affiliation: Department of Dermatology and Allergy, Ludwig-Maximilian-University, Munich, Germany.
authors.forename: Cecilia
authors.initials: C
authors.lastname: Hermans
authors.affiliation: Department of Dermatology and Allergy, Ludwig-Maximilian-University, Munich, Germany.
authors.forename: Thomas
authors.initials: T
authors.lastname: Ruzicka
authors.affiliation: Department of Dermatology and Allergy, Ludwig-Maximilian-University, Munich, Germany.
authors.forename: Markus
authors.initials: M
authors.lastname: Braun-Falco
mesh_terms: D000368:Aged; D001707:Biopsy, Needle; D017024:Chemotherapy, Adjuvant; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology; D005148:Facial Dermatoses / Q000175:diagnosis / Q000209:etiology; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000473:pathology; D008545:Melanoma / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib